🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Self-administered COgnitive Personalized Training in Early Psychosis

RecruitingNAAges 16 Years - 35 YearsAllCentre Hospitalier St Anne
NCT06634446 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The overall objective of SCOPe is to improve early intervention in psychosis by providing an innovative eHealth tool that will enable personalized cognitive training, adapted to the individual's cognitive abilities. Cognitive remediation improves quality of life and functional outcome in patients with chronic psychosis. It would even be more efficacious in the early phase of psychosis by tackling the negative impact of psychosis on education achievement and employment. However, cognitive dysfunctions are often overlooked in FEP and cognitive remediation is not always accessible. New technologies can provide us with youth-friendly, non-stigmatizing tools, such as self administered, training applications so that all first-line clinical settings or professionals, and in fine all patients, can have access, wherever they live, to personalized cognitive training focusing on impaired functions

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adolescent and young adults, both genders, aged 16 to 35, * Seeking help in one of the recruiting centers, * Newly diagnosed as experiencing an Episode of Psychosis (reaching criteria as described in the Comprehensive Assessment of at Risk Mental States (CAARMS) within the year * Written informed consent signed (and from one legal guardian for minors). Exclusion Criteria: * Severe and unstabilized medical conditions, * Insufficient level in reading and/or French language, * Absence of medical insurance, * Participation in another intervention trial, * Enforced hospitalization (ASPDT, ASPPI, ASPRE), * Intellectuel Deficiency (IQ\<70), and / or sensorimotor deficits incompatible with the cognitive training,
💊

What it tests

  • a mobile application for cognitive training
  • video games
📍

Where

1 site
Groupe Hospitalier Universitaire Paris - Psychiatrie et Neurosciences, (GHU Paris)
Paris, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy